Skip to main content
OpenTrials

Clinical trial condition

Male Urogenital Diseases

Explore clinical trials studying Male Urogenital Diseases. Study availability and eligibility vary by location and protocol.

20,874 public trials 3,485 recruiting studies
Refine in advanced search Browse all conditions

Male Urogenital Diseases trial results

Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

NCT05503797

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of California Los Angeles Rheumatology Westwood, Los Angeles, California, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
View all 70 locations
View Trial Details
Recruiting

Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT

NCT05399537

Conditions
Acute Kidney Injury, Acute Kidney Injury (AKI), Continuous Renal Replacement Therapy (CRRT), +8 more
Locations
  • University of Alabama at Birmingham/UAB Birmingham, Alabama, United States
  • University of Southern California (USC) / Keck Hospital Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of Miami Miami, Florida, United States
View all 14 locations
View Trial Details
Recruiting

Cooperative Assessment of Late Effects for SCD Curative Therapies

NCT05153967

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +20 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NCT06465069

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
View all 38 locations
View Trial Details

Related conditions